The page lists 18 projects related to the topic "mainstay".
# | |||
---|---|---|---|
1 | NEPHSTROM | Novel Stromal Cell Therapy for Diabetic Kidney Disease | 2015 |
2 | EpiLIVER | Characterization and implications of DNA damage response in liver cancer | 2016 |
3 | MultiDiag | Rapid, cost-effective, multiplex point of care diagnostic immunoassay system | 2015 |
4 | OPRECOMP | Open transPREcision COMPuting | 2017 |
5 | PAMMOTH | Photoacoustic/Ultrasound Mammoscopy for evaluating screening-detected abnormalities in the breast | 2017 |
6 | CaraSlug | Carabids as biocontrol agents for slugs in Oregon and Ireland - a novel and interdisciplinary approach to determine key malacophagous species and beneficial management options | 2017 |
7 | SODIUMMRI-4-EU | Unlocking the potential of ultrahigh field 23Na magnetic resonance to quantify tissue sodium content for probing viability of the heart: where physics, biology and medicine meet | 2018 |
8 | ThermalMR | Thermal Magnetic Resonance: A New Instrument to Define the Role of Temperature in Biological Systems and Disease for Diagnosis and Therapy | 2018 |
9 | TRIPLECON | Triple negative breast cancer control through synergistic inhibition of EGFR and CDK9 signaling | 2017 |
10 | ProMeta | Non-histone protein acetylation targets of KAT2A in AML | 2018 |
11 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
12 | OptiVerter | Solving the triangle for solar mass adoption – Cost, Efficiency and Simplicity | 2018 |
13 | MgSafe | Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants | 2018 |
14 | 20SInhibitor | Selective 20S proteasome inhibition for multiple myeloma therapy | 2019 |
15 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
16 | TyphiNET | A global multi-institutional Typhoid fever genomic surveillance network to improve global public health outcomes | 2020 |
17 | CHANCE | Structure guided inhibition of IDOL to treat atherosclerosis and the metabolic syndrome | 2019 |
18 | PregnancyAD | Antidepressant discontinuation during pregnancy and relapse risk in the perinatal period | 2021 |